Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

SMMT

Summit Therapeutics Inc

May 30 • 04:00PM ET

10.92

Dollar change +7.99
Percentage change 272.06	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VHT IBB SCHA VTWO LABU SBIO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.17	Insider Own	88.18%	Shs Outstand	701.66M	Perf Week	148.75%
Market Cap	7.67B	Forward P/E	-	EPS next Y	-0.28	Insider Trans	0.04%	Shs Float	82.98M	Perf Month	177.86%
Income	-116.06M	PEG	-	EPS next Q	-0.06	Inst Own	7.12%	Short Float	27.19%	Perf Quarter	140.53%
Sales	0.00M	P/S	-	EPS this Y	75.18%	Inst Trans	-29.20%	Short Ratio	8.81	Perf Half Y	454.31%
Book/sh	0.06	P/B	173.39	EPS next Y	-12.97%	ROA	-53.77%	Short Interest	22.57M	Perf Year	600.00%
Cash/sh	0.22	P/C	48.83	EPS next 5Y	-	ROE	-130.63%	52W Range	1.50 - 5.39	Perf YTD	318.39%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-77.35%	52W High	102.60%	Beta	-1.34
Dividend TTM	-	Quick Ratio	6.97	Sales past 5Y	-28.65%	Gross Margin	-	52W Low	628.00%	ATR (14)	1.07
Dividend Ex-Date	-	Current Ratio	6.97	EPS Y/Y TTM	90.98%	Oper. Margin	0.00%	RSI (14)	78.87	Volatility	89.47% 29.31%
Employees	105	Debt/Eq	2.48	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	7.50
Option/Short	Yes / Yes	LT Debt/Eq	2.39	EPS Q/Q	95.68%	Payout	-	Rel Volume	11.69	Prev Close	2.93
Sales Surprise	-	EPS Surprise	0.00%	Sales Q/Q	-	Earnings	May 01 BMO	Avg Volume	2.56M	Price	10.92
SMA20	152.22%	SMA50	174.91%	SMA200	262.73%	Trades		Volume	29,941,716	Change	272.06%

Date	Action	Analyst	Rating Change	Price Target Change
May-07-24	Initiated	Citigroup	Buy	$7
Mar-26-24	Initiated	Stifel	Buy	$8
Jun-28-18	Downgrade	Janney	Buy → Neutral
May-02-18	Initiated	Janney	Buy
Apr-12-18	Reiterated	Needham	Buy	$30 → $27
Feb-13-18	Initiated	BTIG Research	Buy	$33
Jan-04-18	Initiated	SunTrust	Buy	$24
Dec-01-17	Resumed	H.C. Wainwright	Buy	$16
Nov-16-16	Reiterated	RBC Capital Mkts	Outperform	$26 → $29
Oct-05-16	Reiterated	Needham	Buy	$22 → $30
Sep-16-16	Initiated	H.C. Wainwright	Buy	$26
Mar-30-15	Initiated	Oppenheimer	Outperform	$28
Mar-30-15	Initiated	Needham	Buy	$22

Show Previous Ratings

Today 06:00PM	Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +272.06%
04:50PM	Summit Shares Soar After Cancer Drug Tops Mercks Keytruda (Bloomberg)
03:22PM	Competitor to Merck's Keytruda Worries Some Investors (Barrons.com)
02:29PM	Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China (Business Wire)
May-28-24 12:13PM	Why Summit Therapeutics Stock Is Sinking Today (Motley Fool) -29.29%
07:16AM	Loading…
May-24-24 07:16AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -21.76%
May-02-24 11:42AM	Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript (Insider Monkey) -13.62%
03:15AM	Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ... (GuruFocus.com)
12:00AM	Q1 2024 Summit Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
May-01-24 11:55AM	SMMT Stock Earnings: Summit Therapeutics Reported Results for Q1 2024 (InvestorPlace) +19.59%
07:00AM	Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024 (Business Wire)
Apr-24-24 04:30PM	Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024 (Business Wire)
Apr-11-24 04:30PM	Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors (Business Wire)
Apr-10-24 07:00AM	Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum (Business Wire)
Apr-09-24 04:18PM	CORRECTED-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra named successor (Reuters)
04:05PM	Loading…
04:05PM	Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer (PR Newswire)
Apr-02-24 05:41PM	Insiders Are Buying These 11 Penny Stocks (Insider Monkey)
Mar-29-24 05:43PM	Why Summit Therapeutics Stock Crushed the Market This Week (Motley Fool)
01:35PM	Hedge Fund and Insider Trading News: Cliff Asness, David Tepper, Ray Dalio, Mark Yusko, Baupost Group, Irenic Capital Management, Summit Therapeutics Inc (SMMT), Workday, Inc. (WDAY), and More (Insider Monkey)
Mar-22-24 07:00AM	Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024 (Business Wire) -5.07%
Mar-19-24 09:32AM	Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript (Insider Monkey) -11.79%
Mar-14-24 07:00AM	Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024 (Business Wire) +5.32%
Mar-05-24 07:00AM	Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference (Business Wire) +13.17%
Feb-21-24 08:53AM	Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.89%
01:56AM	Q4 2023 Summit Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-20-24 08:31AM	Summit Therapeutics Inc (SMMT) Reports Comprehensive 2023 Financial Results and Clinical ... (GuruFocus.com) -26.23%
07:00AM	Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023 (Business Wire)
Feb-14-24 10:29AM	Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024 (Business Wire)
07:00AM	Summit Therapeutics to Host Fourth Quarter & Full Year 2023 (Business Wire)
Feb-07-24 07:00AM	Summit Therapeutics to Present at Oppenheimers 34th Annual Healthcare Life Sciences Conference (Business Wire)
09:00AM	Loading…
Jan-08-24 09:00AM	Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire) +16.47%
Jan-03-24 07:30AM	Summit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-08-23 12:27PM	Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 09:07AM	Summit Therapeutics Inc (SMMT) Reports Q3 Financial Results and Operational Progress (GuruFocus.com) -12.16%
07:00AM	Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023 (Business Wire)
Nov-02-23 04:41PM	Laura Chow, MD, Cancer Immunotherapy Trailblazer, Joins Summit as Senior Vice President of Clinical Development (Business Wire)
08:00AM	Ivonescimab's Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023 (PR Newswire)
Oct-31-23 08:00AM	Ivonescimabs Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023 (Business Wire)
Oct-26-23 08:00AM	Summit Therapeutics to Host Q3 2023 Financial Results & Operational Progress Call on November 7, 2023 (Business Wire)
Oct-19-23 08:00AM	H. Jack West, MD, Renowned Oncologist & Lung Cancer Expert, Joins Summit Therapeutics as Vice President of Clinical Development (Business Wire)
Oct-16-23 11:01PM	Insider Buying: COO Manmeet Soni Acquires 2,976,190 Shares of Summit Therapeutics Inc (GuruFocus.com)
07:00AM	Summit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating Officer (Business Wire)
Sep-29-23 12:43PM	25 Biggest Stocks with Negative Beta (Insider Monkey)
Aug-09-23 10:19PM	Q2 2023 Summit Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +10.86%
07:00AM	Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023 (Business Wire)
Aug-02-23 08:00AM	Summit Therapeutics to Host Q2 2023 Financial Results & Operational Progress Call on August 9, 2023 (Business Wire) -6.70%
Jul-11-23 11:48AM	Summit Therapeutics Insiders Up US$558m On US$517m Investment (Simply Wall St.)
Jun-04-23 08:00AM	Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023 (Business Wire)
Jun-01-23 07:30AM	Ivonescimab Updated Data to be Featured at ASCO 2023 (Business Wire)
May-22-23 09:30AM	11 Stocks with Heavy Insider Buying in 2023 (Insider Monkey) -5.36%
May-18-23 09:46AM	After buying recently, Summit Therapeutics Inc. (NASDAQ:SMMT) insiders must be dismayed to see the company's market cap drop to US$1.2b (Simply Wall St.)
May-16-23 01:21PM	Why Shares of Summit Therapeutics Slumped on Tuesday (Motley Fool) -15.85%
11:44AM	Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-11-23 11:18PM	Q1 2023 Summit Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -9.20%
12:20PM	10 Best Stocks to Buy for a Quick Return (Insider Monkey)
07:30AM	Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023 (Business Wire)
May-09-23 07:30AM	Summit Therapeutics Announces First Patient Treated in Phase III HARMONi Clinical Trial Evaluating Ivonescimab (SMT112) (Business Wire)
May-05-23 05:08PM	Why Shares of Summit Therapeutics Soared This Week (Motley Fool) +23.30%
May-03-23 08:30AM	Summit Therapeutics Announces Initial Indications for Clinical Trials for Ivonescimab (SMT112) (Business Wire) +8.61%
Mar-09-23 03:42PM	10 Penny Stocks with Insider Buying (Insider Monkey) -6.58%
07:30AM	Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022 (Business Wire)
Mar-03-23 08:00AM	Summit Therapeutics Closes Fully-Subscribed $500 Million Rights Offering (Business Wire) -21.03%
Feb-23-23 08:00AM	Summit Therapeutics Rights Offering Nearing Expiration Date (Business Wire) -5.24%
Feb-01-23 10:25AM	Bullish insiders bet US$97m on Summit Therapeutics Inc. (NASDAQ:SMMT) (Simply Wall St.) +7.04%
Jan-30-23 08:00AM	Summit Therapeutics Announces Timing for Rights Offering for Up to $500 Million (Business Wire)
Jan-20-23 08:00AM	Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody (Business Wire)
Jan-05-23 09:59AM	We Think Summit Therapeutics (NASDAQ:SMMT) Can Afford To Drive Business Growth (Simply Wall St.) -9.61%
07:00AM	Summit Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-30-22 01:25PM	Why Summit Therapeutics Shares Soared This Week (Motley Fool) -19.96%
Dec-09-22 08:27AM	Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week (Simply Wall St.) +8.59%
Dec-08-22 04:45PM	Why Summit Therapeutics Stock Is Skyrocketing This Week (Motley Fool) +17.21%
Dec-06-22 09:54AM	Summit Therapeutics Shares Surge After Licensing Agreement For Cancer Program (Benzinga) +194.27%
07:30AM	Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody (GlobeNewswire)
Nov-17-22 04:15PM	Summit Therapeutics Appoints Experienced Clinical Leader Dr. Alessandra Cesano to its Board of Directors (GlobeNewswire)
Nov-12-22 07:10AM	Summit Therapeutics Third Quarter 2022 Earnings: US$0.14 loss per share (vs US$0.20 loss in 3Q 2021) (Simply Wall St.)
Nov-09-22 08:30AM	Summit Therapeutics Inc. Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022 (GlobeNewswire)
Oct-20-22 05:15PM	Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022 (GlobeNewswire)
Oct-18-22 08:16AM	Shareholders in Summit Therapeutics (NASDAQ:SMMT) are in the red if they invested five years ago (Simply Wall St.)
Oct-13-22 08:00AM	Summit Therapeutics to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022 (GlobeNewswire)
Oct-04-22 11:49AM	Summit Therapeutics Seeks Partnership For Phase 3 Infection Candidate Development (Benzinga)
Oct-03-22 04:37PM	Summit Therapeutics Appoints Dr. Robert Booth, Renowned Executive and Scientific Leader, to its Board of Directors (GlobeNewswire)
Sep-12-22 09:17AM	10 Best Penny Stocks to Buy in September (Insider Monkey)
Aug-22-22 01:16PM	Why Summit Therapeutics Stock Popped Today (Motley Fool) +48.18%
Aug-20-22 08:37AM	Trade Alert: The Co-CEO & Executive Chairman Of Summit Therapeutics Inc. (NASDAQ:SMMT), Robert Duggan, Has Just Spent US$92m Buying 140% More Shares (Simply Wall St.)
Aug-19-22 11:58AM	Why Summit Therapeutics Stock Is Soaring Today (Motley Fool) +10.00%
Aug-11-22 08:00AM	Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022 (GlobeNewswire)
Aug-09-22 01:37PM	Summit Therapeutics Closes Fully-Subscribed $100 Million Rights Offering (GlobeNewswire)
Aug-02-22 09:25AM	Summit Therapeutics Rights Offering Nearing Expiration Date (GlobeNewswire)
Jul-26-22 04:15PM	Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & President (GlobeNewswire)
Jul-18-22 04:05PM	Summit Therapeutics Announces Commencement of $100 Million Rights Offering (GlobeNewswire)
Jul-14-22 11:35AM	Summit Therapeutics Mulls Additional Trial For Its Once Failed Infection Candidate (Benzinga)
08:30AM	Summit Therapeutics Provides Update on Ridinilazole (GlobeNewswire)
Jun-22-22 04:30PM	Summit Therapeutics Announces $100 Million Rights Offering (GlobeNewswire) +8.00%
Jun-03-22 08:30AM	Summit Therapeutics Upcoming Annual Shareholders Meeting (GlobeNewswire)
Jun-01-22 08:30AM	Summit Therapeutics Appoints Ankur Dhingra as Chief Financial Officer (GlobeNewswire)
May-11-22 04:30PM	Summit Therapeutics Inc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2022 (GlobeNewswire) -8.93%
May-08-22 09:44AM	What Kind Of Shareholders Hold The Majority In Summit Therapeutics Inc.'s (NASDAQ:SMMT) Shares? (Simply Wall St.)
Apr-10-22 08:36AM	Summit Therapeutics Inc. (NASDAQ:SMMT) insiders placed bullish bets worth US$62m in the last 12 months (Simply Wall St.)
Mar-17-22 04:14PM	Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021 (GlobeNewswire) +7.93%
Feb-24-22 04:51AM	We Think Summit Therapeutics (NASDAQ:SMMT) Needs To Drive Business Growth Carefully (Simply Wall St.) +18.84%

Summit Therapeutics, Inc. a biopharmaceutical company, which discovers, develops, and commercializes medicines to treat infectious diseases. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zanganeh Mahkam	Chief Executive Officer	Mar 27 '24	Buy	3.72	54,321	201,874	24,923,800	Mar 27 08:28 PM
Zanganeh Mahkam	Chief Executive Officer	Mar 27 '24	Buy	3.72	26,000	96,720	520,814	Mar 27 08:28 PM
Dhingra Ankur	Chief Financial Officer	Mar 26 '24	Buy	3.75	100,000	375,000	354,958	Mar 27 08:27 PM
Zanganeh Mahkam	Chief Executive Officer	Mar 26 '24	Buy	3.75	30,000	112,500	30,000	Mar 27 08:28 PM
Dhingra Ankur	Chief Financial Officer	Dec 13 '23	Buy	2.17	20,400	44,254	254,958	Dec 13 04:49 PM
Zanganeh Mahkam	Chief Executive Officer	Dec 12 '23	Buy	2.07	5,000	10,350	494,814	Dec 13 05:11 PM
Soni Manmeet Singh	Chief Operating Officer	Oct 13 '23	Buy	1.68	2,976,190	4,999,999	2,976,190	Oct 16 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SMMT

Summit Therapeutics Inc

Upgrade your FINVIZ experience